- Open Access
Correction to: Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma
© The Author(s). 2017
Received: 10 October 2017
Accepted: 10 October 2017
Published: 6 November 2017
The original article was published in Journal for ImmunoTherapy of Cancer 2017 5:73
Unfortunately, after publication of this article , it was noticed that the name of Maarten A. Ligtenberg was displayed incorrectly as Maarten Ligtenberg. The correct author list can be seen above and the original article has been updated to reflect this.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Kremer V, Ligtenberg M, Zendehdel R, Seitz C, Duivenvoorden A, Wennerberg E, Lundqvist A. Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma. Journal for Immunotherapy of Cancer. 2017;5:73. https://doi.org/10.1186/s40425-017-0275-9.View ArticlePubMedPubMed CentralGoogle Scholar